GE HealthCare is trading at $75.53, up 6.22%, after third-quarter revenue and adjusted EPS beat analyst expectations and management raised its 2026 outlook.
- Revenue was $5.5 billion versus $5.35 billion expected; adjusted EPS was $1.34 versus $1.20 expected.
- Management raised 2026 adjusted EPS guidance to $4.95–$5.05 from $4.80–$5.00, and expects organic revenue growth of about 4.0%.
- Broad-based segment growth and improved margins also supported results.